13D Filing: James E. Flynn and Homology Medicines Inc (FIXX)

Page 4 of 20

Page 4 of 20 – SEC Filing

 SCHEDULE 13D

CUSIP No.  438083107 Page 4 of 18 Pages
1

NAME OF REPORTING PERSONS

Deerfield Mgmt,
L.P.

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐

(b) ☒

3

SEC USE ONLY

4

SOURCE OF FUNDS

AF

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)

6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

 

 

 NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

7

SOLE VOTING POWER

0

8

SHARED VOTING POWER

625,000 (2)

9

SOLE DISPOSITIVE POWER

0

10

SHARED DISPOSITIVE POWER

625,000 (2)

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

625,000 (2)

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES*

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

1.67%

14

TYPE OF REPORTING PERSON

PN

(2) Comprised of shares held by Deerfield Partners, L.P.

Follow Q32 Bio Inc. (NASDAQ:QTTB)

Page 4 of 20